Since the outbreak of COVID-19, the pharma industry has moved with unprecedented speed to progress vaccines through clinical trials safely, while simultaneously ramping up production on the chance of success.
As the world awaits news from these expedited clinical trials, however, we must also acknowledge that the task of vaccinating the world against COVID-19 won’t be easy – especially when it comes to bringing the public on side.
This paper uses Ipsos research to highlight the obstacles and opportunities that lie ahead – and the importance of building public support in determining any vaccine’s success.
EVENT | The Future of Fats, Sugar and the Obesity Crisis
It can be easy to forget, but the world is facing more than one pandemic. Thirty-nine percent of the global population is overweight. In the UK, that figure is even higher: 67% of adults are overweight. But what makes this crisis so hard to tackle?